XNYS · Laboratory Analytical Instruments · S&P 500
$155.46
-$1.00 (-0.64%) today
Open $156.46 High $158.22 Low $155.12 Vol 403K Avg $156.24
Find similar stocks by technical condition — S&P 500 universe
| Symbol | Company Name | Exchange | Currency | Category |
|---|---|---|---|---|
| SINT | SiNtx Technologies, Inc. Common Stock | XNAS | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| BAX | Baxter International Inc. | XNYS | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| BSX | Boston Scientific Corp. | XNYS | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| TNON | Tenon Medical, Inc. Common Stock | XNAS | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| SSII | SS Innovations International Inc. Common Stock | XNAS | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| IART | Integra LifeSciences Holdings | XNAS | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| NVNO | enVVeno Medical Corporation Common Stock | XNAS | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| NEGG | Newegg Commerce, Inc. Common Shares | XNAS | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| MMM | 3M Company | XNYS | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| XTNT | Xtant Medical Holdings, Inc. | XASE | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
52-week price range
Price is 112.5% above its 52-week low and 3.8% below its 52-week high. Trading in the upper half of its annual range — closer to the peak than the base.
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.